Genital Diseases, Female
Welcome,         Profile    Billing    Logout  
 270 Companies   374 Products   374 Products   160 Mechanisms of Action   39 Trials   5519 News 


«12...1011121314151617181920...110111»
  • ||||||||||  Nexplanon (etonogestrel implant) / Organon
    Trial primary completion date:  vMICROb: Long-Acting Progestin Contraception and the Vaginal Microbiome (clinicaltrials.gov) -  May 19, 2017   
    P=N/A,  N=35, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Apr 2017 --> Apr 2018
  • ||||||||||  TOL-463 / Toltec Pharma
    Enrollment closed, Trial primary completion date:  TOL-463 Phase 2 Study for Vaginitis (clinicaltrials.gov) -  May 19, 2017   
    P2,  N=106, Active, not recruiting, 
    Trial primary completion date: Apr 2017 --> Apr 2018 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2017 --> Jun 2017
  • ||||||||||  defactinib (VS-6063) / Verastem
    Trial completion, Trial primary completion date, Combination therapy, Metastases:  Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer (clinicaltrials.gov) -  May 17, 2017   
    P1,  N=22, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2017 --> Jun 2017 Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Feb 2015
  • ||||||||||  Preclinical, Trial primary completion date:  Use of IMSI in Poor Responders to IVF (clinicaltrials.gov) -  May 10, 2017   
    P=N/A,  N=200, Recruiting, 
    Trial primary completion date: Jan 2017 --> Jul 2017 Trial primary completion date: Jan 2017 --> Jan 2018
  • ||||||||||  clomifene citrate / Generic mfg.
    Preclinical, Enrollment change, Trial withdrawal:  IVF Versus Gonadotropin Therapy in Women With CC Resistant PCOS (clinicaltrials.gov) -  May 10, 2017   
    P4,  N=0, Withdrawn, 
    Trial primary completion date: Jan 2017 --> Jun 2017 N=100 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  clomifene citrate / Generic mfg.
    Preclinical, Enrollment change, Trial withdrawal:  IVF Versus LOD in Women With CC Resistant PCOS (clinicaltrials.gov) -  May 10, 2017   
    P4,  N=0, Withdrawn, 
    N=100 --> 0 | Not yet recruiting --> Withdrawn N=100 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  Trial completion, Preclinical:  Low-dose GH Supplementation Increases Clinical Pregnancy Rate (clinicaltrials.gov) -  May 10, 2017   
    P1,  N=64, Completed, 
    N=100 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed
  • ||||||||||  lorazepam / Generic mfg., ibuprofen / Generic mfg.
    Trial primary completion date:  Analgesia for Endometrial Scratching (clinicaltrials.gov) -  May 9, 2017   
    P=N/A,  N=150, Enrolling by invitation, 
    Active, not recruiting --> Completed Trial primary completion date: Mar 2017 --> Sep 2017
  • ||||||||||  Enrollment closed:  Does Skyla Insertion Timing Impact Bleeding? (clinicaltrials.gov) -  May 8, 2017   
    P=N/A,  N=132, Active, not recruiting, 
    Recruiting --> Completed Recruiting --> Active, not recruiting
  • ||||||||||  Trial primary completion date:  Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive (clinicaltrials.gov) -  May 4, 2017   
    P=N/A,  N=154, Active, not recruiting, 
    Active, not recruiting --> Completed | N=56 --> 22 | Trial primary completion date: Dec 2017 --> Jul 2016 Trial primary completion date: Dec 2017 --> Dec 2018
  • ||||||||||  metformin / Generic mfg.
    Trial primary completion date:  Metformin for the Treatment of Endometrial Hyperplasia (clinicaltrials.gov) -  May 4, 2017   
    P,  N=18, Active, not recruiting, 
    Trial primary completion date: Dec 2017 --> Dec 2018 Trial primary completion date: Dec 2016 --> Dec 2015
  • ||||||||||  Utrogestan (progesterone) / Besins Healthcare
    Preclinical, Trial primary completion date:  Implantation Enhancement by Elective Cryopreservation of All Viable Embryos (clinicaltrials.gov) -  May 4, 2017   
    P=N/A,  N=212, Recruiting, 
    Trial primary completion date: Dec 2016 --> Dec 2015 Trial primary completion date: Dec 2016 --> Dec 2017
  • ||||||||||  Trial primary completion date, Head-to-Head:  SALPINGOVA: Effect of Salpingectomy During Conservative Hysterectomy (clinicaltrials.gov) -  May 4, 2017   
    P=N/A,  N=350, Recruiting, 
    Trial primary completion date: Jun 2017 --> Dec 2017 Trial primary completion date: Sep 2016 --> Aug 2017
  • ||||||||||  Trial completion:  Recruiting African American Fathers/ Sons (clinicaltrials.gov) -  May 4, 2017   
    P=N/A,  N=28, Completed, 
    Recruiting --> Completed Recruiting --> Completed
  • ||||||||||  trebananib (AMG 386) / Amgen
    Trial termination:  AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) (clinicaltrials.gov) -  May 4, 2017   
    P3,  N=223, Terminated, 
    Recruiting --> Completed Active, not recruiting --> Terminated; Closure of long term follow up (LTFU) and study earlier than previously outlined in the protocol as no beneficial information gained from continuing LTFU.
  • ||||||||||  Trial completion, Enrollment change, Trial initiation date, Trial primary completion date:  The Effect of a Coloring Prompt on Health Engagement (clinicaltrials.gov) -  May 4, 2017   
    P=N/A,  N=8711, Completed, 
    Active, not recruiting --> Terminated; Closure of long term follow up (LTFU) and study earlier than previously outlined in the protocol as no beneficial information gained from continuing LTFU. Recruiting --> Completed | N=15000 --> 8711 | Initiation date: May 2014 --> May 2011 | Trial primary completion date: Dec 2016 --> Nov 2012
  • ||||||||||  trebananib (AMG 386) / Amgen
    Trial completion, Enrollment change, Trial primary completion date:  Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer (clinicaltrials.gov) -  May 4, 2017   
    P2,  N=35, Completed, 
    Recruiting --> Completed | N=15000 --> 8711 | Initiation date: May 2014 --> May 2011 | Trial primary completion date: Dec 2016 --> Nov 2012 Active, not recruiting --> Completed | N=55 --> 35 | Trial primary completion date: Mar 2016 --> Jul 2016
  • ||||||||||  Trial primary completion date:  Yoga Practice for Breast or Ovarian Cancer Patients (clinicaltrials.gov) -  May 3, 2017   
    P=N/A,  N=39, Active, not recruiting, 
    Active, not recruiting --> Completed | N=55 --> 35 | Trial primary completion date: Mar 2016 --> Jul 2016 Trial primary completion date: Nov 2017 --> Nov 2018
  • ||||||||||  clomifene citrate / Generic mfg.
    Trial completion, Enrollment change:  NAC in CC Resistant PCOS After LOD (clinicaltrials.gov) -  May 2, 2017   
    P2/3,  N=144, Completed, 
    Initiation date: Feb 2017 --> Jun 2017 Recruiting --> Completed | N=120 --> 144
  • ||||||||||  Trial initiation date, Trial suspension, Trial primary completion date, HEOR, Metastases:  Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer (clinicaltrials.gov) -  May 2, 2017   
    P=N/A,  N=40, Suspended, 
    Active, not recruiting --> Completed Initiation date: Jul 2016 --> Jan 2018 | Not yet recruiting --> Suspended | Trial primary completion date: Nov 2017 --> Jan 2020
  • ||||||||||  Enrollment closed, Enrollment change, Trial primary completion date:  Effect of Sorting of Apoptotic Spermatozoa on the Outcome of Assisted Reproduction (clinicaltrials.gov) -  May 1, 2017   
    P=N/A,  N=100, Active, not recruiting, 
    Initiation date: Jul 2016 --> Jan 2018 | Not yet recruiting --> Suspended | Trial primary completion date: Nov 2017 --> Jan 2020 Recruiting --> Active, not recruiting | N=200 --> 100 | Trial primary completion date: Dec 2015 --> Jan 2017
  • ||||||||||  Enrollment change, Trial termination:  Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media (clinicaltrials.gov) -  May 1, 2017   
    P=N/A,  N=13, Terminated, 
    Recruiting --> Active, not recruiting | N=200 --> 100 | Trial primary completion date: Dec 2015 --> Jan 2017 N=100 --> 13 | Recruiting --> Terminated; Lack of recruitment